Gopa Kanungo’s body may have been battered by the chronic ailment, but her spirit has not. She tells us how she manages the auto-immune disease, Lupus.
A few weeks ago, on my 50th birthday, I woke up in the morning and did a quick rewind of my life. Perhaps everyone, who hits that landmark, does. But in my case, it was a personal triumph like no other. In the last two decades, my body has been battered by two life-threatening ailments.
ImmuPharma PLC (LON:IMM) is headquartered in London and has its research operations in France (ImmuPharma (France) SA) and Switzerland (ImmuPharma AG). ImmuPharma is dedicated to the development of innovative drugs to treat serious medical conditions, characterised by High unmet medical need, Low marketing costs and Relatively low development costs